Context: Fundamental case study of an Indian listed fertilizer company

Classification: Long-term equity research (Krishana Phoschem Ltd – NSE: KRISHANA)

---

1. Company snapshot

- Name: Krishana Phoschem Limited (KPL) (krishnaphoschem.com)

- CIN / Incorporation: L24124RJ2004PLC019288; incorporated 14 May 2004 (zaubacorp.com)

- Registered office: Bhilwara, Rajasthan

- Listing: National Stock Exchange of India (NSE) (krishnaphoschem.com)

- Sector: Fertilizers & agrochemicals – phosphatic fertilizers and related industrial chemicals (krishnaphoschem.com)

- Group: Part of the Ostwal group (related-party transactions with Ostwal Phoschem (India) Ltd, Madhya Bharat Agro Products Ltd, Shri Ganpati Fertilizers Ltd) (krishnaphoschem.com)

- Credit rating: CRISIL A / Stable on borrowings (FY23–24) (krishnaphoschem.com)

Positioning: KPL has evolved from a single-super-phosphate (SSP) player into a backward-integrated phosphatic fertilizer and chemicals producer with complex fertilizers (DAP/NPK), phosphoric acid and sulphur-based intermediates. (krishnaphoschem.com)

---

2. Business model and product portfolio

2.1 Product & segment mix

Key manufactured products (as per FY23–24 AR): (krishnaphoschem.com)

- Fertilizers

- Single Super Phosphate (SSP) – powder and granular (GSSP)

- Di-Ammonium Phosphate (DAP)

- NPK complex fertilizers (Nitrogen–Phosphorus–Potassium)

- Intermediates / Chemicals

- Beneficiated Rock Phosphate

- Phosphoric Acid

- Sulphuric Acid (SA)

- Oleum

- Chloro Sulphonic Acid

- Liquid SO₃

- H-Acid (chemical product)

Integration logic:

- Backward integration into rock beneficiation, sulphuric acid and phosphoric acid gives KPL cost and supply security for SSP and DAP/NPK. (krishnaphoschem.com)

- Forward integration into complex fertilizers (DAP/NPK) adds higher-value, brandable products on top of bulk SSP.

- Group entities (like Madhya Bharat Agro Products) provide sourcing/sales synergies via related-party transactions (approved by shareholders as material RPTs). (krishnaphoschem.com)

Revenue is largely from fertilizer manufacturing, distribution and sale of crop protection and nutrition products, which together account for the bulk of turnover. (krishnaphoschem.com)

---

3. Operations and capacities – case study angle

From the FY23–24 Directors’ Report (standalone): (krishnaphoschem.com)

- FY23–24 production volumes:

- 61,526 MT of Beneficiated Rock Phosphate

- 113,291 MT of SSP (incl. micronutrient-enriched)

- 150,466 MT of Sulphuric Acid / Oleum / CSA and related products

- 97,671 MT of NPK complex fertilizer

- 48,171 MT of Phosphoric Acid

- 51,291 MT of DAP

KPL started commercial manufacturing of DAP, NPK and phosphoric acid in Feb 2023, so FY23–24 and FY24–25 are the first full years of ramp-up for these higher-value segments. (krishnaphoschem.com)

This ramp-up is central to the case study: the company is transitioning from a mid-sized SSP/chemicals player to a scaled complex fertilizer manufacturer, using earlier investments in intermediates (sulphuric/phosphoric acid, rock beneficiation) to support this growth.

---

4. Financial performance – 5-year view (FY21–FY25) and FY26 update

4.1 5-year standalone financial trend (up to FY25)

Data below is standalone, rounded, from Smart‑Investing (Accord Fintech). (smart-investing.in)

Key observations (illustrative, not advice):

- Explosive scale-up: Revenue grew from ₹323 Cr in FY23 to ₹924 Cr in FY24 (+186% YoY) and ₹1,358 Cr in FY25 (+47% YoY), driven largely by complex fertilizers and chemicals. (smart-investing.in)

- Profit compounding: PAT grew from ₹27 Cr (FY23) to ₹40 Cr (FY24) to ₹87 Cr (FY25). EPS rose from ₹6.54 (FY24) to ₹14 (FY25), +114% YoY post-bonus. (smart-investing.in)

- Return ratios improving: ROE improved to 25.3% and ROCE to 21.8% in FY25 as new capacities ramped but were still early in the cycle. (smart-investing.in)

- Leverage increased vs pre-capex years: Debt/Equity peaked around 1.45x in FY24 and moderated to ~0.98x in FY25, reflecting capex-led growth funded partly by borrowings. (smart-investing.in)

4.2 FY26 audited results – latest available

As per the company’s audited FY26 results for year ended 31 March 2026: (scanx.trade)

- Revenue from operations (FY26): ₹241,800.11 lakh (~₹2,418 Cr) vs ₹135,823.89 lakh (~₹1,358 Cr) in FY25 – ~78% YoY growth.

- Net profit (FY26): ₹18,014.69 lakh (~₹180 Cr) vs ₹8,653.95 lakh (~₹86.5 Cr) in FY25 – >100% YoY growth.

- Q4 FY26 performance: Revenue ₹755.5 Cr and PAT ₹83.1 Cr, sharply higher than Q4 FY25 (₹472.9 Cr revenue; ₹32.9 Cr PAT).

- EPS (FY26): ₹29.14 (basic & diluted) vs ₹14.00 in FY25.

- Balance sheet (31 Mar 2026):

- Total assets: ₹1,64,070.50 lakh

- Total equity: ₹56,072.30 lakh

- Total borrowings: ₹73,254.24 lakh (≈₹732.5 Cr: non-current ₹154.4 Cr, current ₹578.2 Cr)

- Implied Debt/Equity ~1.3x (higher than FY25, in line with heavy working capital and capex).

From a case-study perspective, FY26 confirms a second consecutive year of very high growth with profitability scaling faster than revenue, indicating operating leverage on largely fixed-cost plants – but also a sharp rise in receivables and inventories, characteristic of subsidy- and credit-driven fertilizer distribution. (scanx.trade)

---

5. Capital structure, dividends and governance

- Equity base: Paid-up equity share capital increased from ₹30.91 Cr to ₹61.83 Cr in FY24 via a 1:1 bonus issue (Oct 2023). (krishnaphoschem.com)

- Dividends:

- FY23–24: Final dividend of 5% (₹0.50/share) on ₹10 FV shares recommended. (krishnaphoschem.com)

- FY25–26: Again, final dividend of ₹0.50/share (5%) recommended, indicating a stable but modest payout policy despite high growth. (scanx.trade)

- Auditor’s opinion: Statutory auditors (M/s Ashok Kanther & Associates) have consistently issued unmodified opinions on financials; no adverse remarks in secretarial or cost audit reports as per FY23–24 AR. (krishnaphoschem.com)

---

6. Strategic strengths (analytical view – not advice)

1. Integrated phosphatic chain

- Control over rock beneficiation, sulphuric and phosphoric acid supplies enhances margin resilience vs pure blenders/importers. (krishnaphoschem.com)

2. Shift toward higher-value fertilizers

- DAP/NPK share is rising, which typically commands better realisations and stronger farmer brand recall than standalone SSP. (krishnaphoschem.com)

3. Strong growth metrics

- Revenue CAGR (FY21–FY25) >60% and PAT CAGR ~45% per Smart‑Investing; FY26 further accelerates this trajectory. (smart-investing.in)

4. Return ratios improving with scale

- ROE/ROCE have moved into 20%+ territory in FY25, and FY26 profit growth suggests further improvement (exact FY26 ROE/ROCE not yet compiled in public analytics at the time of writing, but balance sheet and PAT imply healthy returns). (scanx.trade)

5. Credit rating & governance

- CRISIL A/Stable rating supports bank funding and indicates satisfactory risk profile; ARs and secretarial reports show no major governance red flags reported so far. (krishnaphoschem.com)

---

7. Key risks & monitoring factors

(Analytical discussion only, not a recommendation)

1. Regulatory & subsidy risk

- Fertilizer sector is highly regulated (nutrient-based subsidy, price caps, freight subsidies). Delays in subsidy release and policy shifts can stress working capital and margins.

2. Raw material volatility & import dependence

- Rock phosphate, phosphoric acid (for conversion), ammonia and sulphur are globally traded commodities with high price volatility; although KPL has backward integration, it still depends on imports and global pricing cycles. (krishnaphoschem.com)

3. Working capital intensity

- Rapid FY26 growth is accompanied by sharp increases in trade receivables and inventories; receivables rose to ~₹715 Cr and inventories to ~₹311 Cr as of 31 Mar 2026. This can pressure cash flows and necessitate high short-term borrowings. (scanx.trade)

4. Leverage & capex execution

- FY26 Debt/Equity has moved to ~1.3x including working-capital borrowings. While not extreme for a capex-heavy player, any downturn in fertilizer demand or subsidy delays could strain coverage metrics.

5. Commodity & agri-cyclicality

- Monsoon variability, crop prices and farm economics impact fertilizer offtake. High fixed costs and large plants make results sensitive to utilisation levels.

6. Related-party transactions

- Significant volumes with group entities (Ostwal Phoschem, Madhya Bharat Agro Products, Shri Ganpati Fertilizers) demand continuous scrutiny to ensure arm’s-length pricing and minority shareholder protection. (krishnaphoschem.com)

---

8. Valuation and market view – how to use this case study

- Live share price and valuation multiples change daily, and live market data is not being provided here.

- As of an earlier reference point (4 Nov 2025), third-party analytics show KPL traded around ₹505.7/share, with TTM EPS ~₹19 and P/E ~26.7x, and market cap ~₹3,125 Cr. This is historical and not indicative of current levels in April 2026. (smart-investing.in)

- For your own analysis (example approach, not advice), you can:

- Compare current P/E and EV/EBITDA vs peers such as Coromandel International, Chambal Fertilisers, Deepak Fertilisers, FACT, PPL, etc. (smart-investing.in)

- Assess whether FY26 growth is cyclical or structural (DAP/NPK ramp-up, capacity utilisation, pricing vs subsidies). (scanx.trade)

- Stress-test cash flows under slower growth / lower spreads given the higher debt and working capital.

For latest price and filings, always refer to:

- NSE company page (symbol: KRISHANA) – for real-time price, announcements, financial results.

- Company’s own website – for annual reports, concall presentations and BRSR. (screener.in)

---

If you want, I can next:

- Build a simple projection model (illustrative) using FY26 as base, or

- Compare Krishana Phoschem’s fundamental profile against 2–3 key listed fertilizer peers on growth, margins, ROCE, and leverage.

If you have any further queries, please connect with us on 022-6290-10141 (Timings : 09.00 AM to 05.00 PM) or you can email us on info@cniinfoxchange.com